Commentary · 1 Jul 2026
Conference abstractPublished 21 Nov 2018
Real world data in the new era of clinical research
Maria Cecilia Hospital, Italy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The clinical research has been marked by significant events that have revolutionized the way to do research. Although the Randomized Clinical Trial (RCT) is the gold standard for establishing the effectiveness of a treatment, it is however well known that it is characterized by a series of important limitations. Due to the ethical and scientific criteria and rigorous methodological that characterize them, the RCTs usually experience a single pharmacological therapy in a highly selected group of patients. For these reasons, it is quite rare that in the course of the RCTs there may be identified beneficial effects on outcomes not foreseen by the study protocol, phenomena of drug interactions as well as rare adverse events or appearing as a result of long-term therapies. For these characteristics, the RCTs lack the so-called external validity. Today begins a new era of clinical research, based on the use of Real World Data (RWD) on the efficacy and safety of pharmacological. Based on these assumptions, the need for RWDs is founded, as a tool to implement knowledge on health services, to generate new evidence, respond to unresolved clinical questions and to promote the development of personalized medicine. The analysis and interpretation of the RWD, or that data collected in the absence of a predetermined question will produce real scientific evidence, better defined as Real-World Evidence.
Subjects
Genetics & Molecular BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Genetic Syndromes & Gene Therapy.
Perspective · 1 Jul 2026
Lentiviral Gene Integration Systems in Hematologic Genetic Blood Disorders
Perspective · 1 Jul 2026
Programmable RNA Editing Systems in Congenital Skeletal Dysplasia Disorders
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Genetic Syndromes & Gene Therapy
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Elena Tenti”
